GLP-1 Agonists vs. DPP-4 Inhibitors for Alcohol/Substance Use Disorders in HIV Patients

Health & Human Services (HHS)Sol: 75N95026R00007

TBD

est. $24K – $89K

This opportunity is closed

The response deadline has passed. Review the details for future reference or to track similar opportunities.

Quick Brief

The Department of Health and Human Services is procuring research services to evaluate the effectiveness of Glucagon-like Peptide-1 receptor agonists compared to DPP-4 inhibitors in treating alcohol and substance use disorders among individuals living with HIV. The key requirement is to assess how these treatments can improve HIV-related health outcomes and overall health benefits for this population.

Generated 30d ago

Attachments (1)

Sources Sought Notice .pdf

PDF·277.4 KB

View all on SAM.gov

Contract Details

Contract Type: TBD
Estimated Value: est. $24K – $89K
Similar contracts award $24K – $305K (median $89K, 11,390 awards)Within typical range
NAICS Codes

Agency & Contact

Contracting Organization

Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Point of Contact

John A. Smith

Contracting Officer

[email protected]

(202) 555-0100

Key Dates

Published1mo ago

Apr 22, 2026

Response Due28d ago

May 6, 2026

Description

https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=df3e85dd8d924d86af74fcb7896efb6b

Get matched to contracts like this daily

Free AI-powered contract matching for your business.